Browsing Tag

Partnering

580 posts

Gilead, Arcus Biosciences Close Deal for $2-Bn Immunotherapy Pact
By

By
Gilead Sciences and Arcus Biosciences, a Hayward, California clinical-stage company focused on cancer immunotherapies, have closed their deal for a 10-year partnership, worth up to $2 billion, to co-develop and…

Pharma COVID Roundup: News from Moderna, Pfizer, Gilead, Novartis
By

By
The latest on manufacturing and potential treatments for COVID-19 from Moderna, Pfizer, Gilead, Novartis, AstraZeneca, Emergent BioSolutions, CSL Behring, and Biocon. Moderna To Begin Phase III Trials for COVID-19 Vaccine…

Global Pharma Briefs: News from Asia, Europe and the US
By

By
A roundup of news from China (Boehringer Ingelheim), Europe (J&J), and the US (Lupin, Merck & Co., Sandoz, Civica Rx, and Mylan). China Boehringer Ingelheim Launches External Innovation Hub in…

Regeneron Gets $450-M US Gov’t Contract for COVID-19 Antibody Cocktail
By

By
Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, has been awarded a $450-million contract from the US government to manufacture and supply REGN-COV2, Regeneron’s investigational double antibody cocktail that is…

Pharma COVID Roundup: News from Sanofi, Mylan, GSK and CSL Behring
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from Sanofi, Mylan, GSK, Moderna, CSL Behring, CureVac, Sinovac, Zydus Cadila, and the WHO. News from Sanofi, Mylan, GSK,…

Merck & Co., Foghorn Therapeutics in $425-M Deal for Oncology Drugs
By

By
Merck & Co. and Foghorn Therapeutics, a Cambridge, Massachusetts-based gene-therapy company, have formed a strategic collaboration, in a deal worth up to $425 million, to discover and develop therapeutics against…

Novavax Receives $1.6 Bn in Funding from US’ Operation Warp Speed
By

By
Novavax, a Gaithersburg, Maryland-based clinical-stage vaccine company, has been awarded $1.6 billion by the US government to participate in Operation Warp Speed (OWS), a US government program that aims to begin…

Global Pharma Briefs: News from Asia, Europe, and the US
By

By
A roundup of news from Japan (Fujifilm), the UK (BI, Hikma, Perrigo) and the US (Nabriva Therapeutics, Lupin, Unichem, GSK, and La Jolla Pharmaceuticals). Japan Fujifilm Announces Approval of Adalimumab…

Pharma COVID Roundup: News from AstraZeneca, Pfizer, Gilead, Merck & Co.
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from AstraZeneca, Pfizer, Gilead Sciences, Daiichi Sankyo, Merck & Co., Merck KGaA, and others. News from AstraZeneca, Daiichi Sankyo,…

Takeda, Carmine Therapeutics in $900-M Pact for Non-Viral Gene Therapies
By

By
Takeda and Carmine Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company, have signed a research collaboration agreement to discover, develop and commercialize non-viral gene therapies for two rare disease targets, in a…